Skip to main content

Korro Bio to Participate in 2022 Jefferies Healthcare Conference

Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference, being held in New York, NY, on Thursday, June 9, 2022, at 10:30 a.m. EDT.

About Korro Bio, Inc.

Korro is an RNA editing company focused on discovery and development of a new class of precision genetic medicines. Korro’s proprietary and modular platform, OPERATM, combines data-driven design with off-the-shelf chemistry and delivery to achieve highly selective RNA editing. This unique technology enables the functional benefits of gene therapy with a transient, repeated-administration regimen that permits pharmacologic titration of therapeutic efficacy and safety, in a cost-effective drug product. As a result, Korro’s portfolio of innovative RNA therapies have the potential to propel genetic medicine beyond rare genetic diseases into larger patient populations with common diseases. Korro is located in Cambridge, Mass. For more information, visit korrobio.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.92
+6.44 (2.97%)
AAPL  263.42
+1.18 (0.45%)
AMD  239.13
-1.43 (-0.59%)
BAC  51.72
-0.32 (-0.62%)
GOOG  252.13
-4.88 (-1.90%)
META  732.47
+0.30 (0.04%)
MSFT  517.12
+0.33 (0.06%)
NVDA  181.26
-1.38 (-0.75%)
ORCL  275.42
-1.76 (-0.64%)
TSLA  445.79
-1.64 (-0.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.